Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial

  • Jeffrey M. Pernica,
  • Andrew P. Steenhoff,
  • Margaret Mokomane,
  • Banno Moorad,
  • Kwana Lechiile,
  • Marek Smieja,
  • Loeto Mazhani,
  • Ji Cheng,
  • Matthew S. Kelly,
  • Mark Loeb,
  • Ketil Stordal,
  • David M. Goldfarb

The dose of Lactobacillus reuteri DSM 17938 appears incorrectly throughout the article as 5x108 colony-forming units (cfu) per day. The correct dose of of Lactobacillus reuteri DSM 17938 should be 1x108 cfu per day.

Reference

  1. 1. Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, et al. (2017) Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS ONE 12(10): e0185177. https://doi.org/10.1371/journal.pone.0185177 pmid:28991918

Citation: Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, et al. (2018) Correction: Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. PLoS ONE 13(3): e0194957. https://doi.org/10.1371/journal.pone.0194957

Published: March 21, 2018

Copyright: © 2018 Pernica et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.